EGFR and head and neck squamous cell carcinoma: Besides, D1 (A12) restrains the progression of head and neck squamous cell carcinoma by reducing HERS-transactivation induced by retarded hormone and even has therapeutic prospects for EGFR TKI-resistant head and neck squamous cell carcinoma (276).